Free Trial
OTCMKTS:HSTC

HST Global (HSTC) Stock Price, News & Analysis

$0.83 0.00 (0.00%)
As of 05/13/2025

About HST Global Stock (OTCMKTS:HSTC)

Key Stats

Today's Range
$0.83
$0.83
50-Day Range
$0.51
$0.83
52-Week Range
$0.23
$1.11
Volume
N/A
Average Volume
1,185 shs
Market Capitalization
$47.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

HST Global, Inc., operates as an integrated health and wellness biotechnology company in the United States. The company develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer and other life threatening diseases. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancer and or/ life threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.

Receive HSTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HST Global and its competitors with MarketBeat's FREE daily newsletter.

HSTC Stock News Headlines

HST Global Delays Yearly Report Filing
HST Global Delays Form 10-K Filing
BITCOIN
Liquidity pools are the backbone of crypto—and right now, they’re exploding with activity. By providing liquidity, you could tap into bonus payouts up to 69% over the next two months. But the clock is ticking before Wall Street moves in.
HST Global Inc HSTC
Vinaconex Investment and Tourism Development JSC
See More Headlines

HSTC Stock Analysis - Frequently Asked Questions

HST Global's stock was trading at $0.85 at the beginning of 2025. Since then, HSTC shares have decreased by 2.4% and is now trading at $0.83.
View the best growth stocks for 2025 here
.

HST Global, Inc. (OTCMKTS:HSTC) released its quarterly earnings results on Monday, November, 20th. The company reported $0.00 earnings per share for the quarter.

Shares of HSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/20/2017
Today
5/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:HSTC
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-150,000.00
Pretax Margin
N/A
Return on Equity
-13,072.91%

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
16,328,000
Market Cap
$47.95 million
Optionable
Not Optionable
Beta
-1.19
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:HSTC) was last updated on 5/14/2025 by MarketBeat.com Staff
From Our Partners